Abstract
Bacteria have become resistant to many antibiotics over the last twenty years. Practitioners, who were highly optimistic in the 1950s and 1960s in treating infections empirically with available antibiotics, are now discovering that empiric treatment in hospitals is only effective when broad-spectrum antibiotics are used that cover many bacteria. This is because of the unforeseen rise in resistance to antibiotics. Tailored antimicrobial treatment is only possible after the results of cultures and susceptible testing are obtained from a diagnostic laboratory (McGowan Jr. and Metchock, 1995).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Afzal-Shah, M., and M., Livermore, D.M., 1998, Letter. Worldwide emergence of carbapenem-resistant Acinetobacter spp. J. Antimicrob. Chemother. 41 576-577.
Aubry-Damon, H., Legrand, P., Brun-Buisson, C., et al., 1997, Reemergence of Gentamicinsusceptible strains of methicillin-resistant Staphylococcus aureus roles of an infection control program and changes in aminoglycoside use. Clin. Infect. Dis. 25 647-653.
Branger, C., Lesimple, A.L., Bruneau, B., Berry, P., and Lambertzechovsky N., 1998, Long-term investigation of the clonal dissemination of Klebsiella pneumonia isolates producing extended-spectrum beta-lactamases in a university hospital, J. Med. Microbiol. 47 201-209.
Brunet, F., Vedel G., Dreyfus, F., et al., 1990, Failure of teicoplanin therapy in two neutropenic patients with staphylococcal septicemia who recovered after administration of vancomycin. Eur. J. Clin. Microbio!. Infect. Dis. 9 145-147.
Centres for Disease Control. United States, 1997, Staphylococcus aureus with reduced susceptibility to vancomycin? MMWR 46: 765-766.
The Economist, May 31, 1997, Resisting resistance; pp. 87-88.
Felmingham, D., Brown, D.F., and Soussy, C.J., 1998, European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group. Diagn. Microbiol. Infect. Dis.; 31 563-571.
Fitch, L., and Johnson, A.P., 1998, Reduced susceptibility to teicoplanin in a methicillinresistant strain of Staphylococcus aureus. J. Antimicrob. Chemother. 1 578.
Fluit, A.C., Schmitz, F-J., Jones, M.E., et al.,1999, for the SENTRY Participants Group 1998. Antimicrobial resistance among community-acquired pneumonia isolates in Europe: first results from the SENTRY antimicrobial surveillance program 1997. Int. J Infect. Dis. 3 153-156.
Fridkin, S.K., Yokoe, D.S., Whitney, C.G., et al., 1998, Epidemiology of a dominant clonal strain of vancomycin-resistant Enterococcus faecium at separate hospitals in Boston, Massachusetts. J. Clin. Microbio!. 36 965-970.
Gillespie, M.T., Lyon B.R., Messerotti L.J., and Skurray R.A., 1987, Chromosome and plasmid mediated gentamicin resistance in Staphylococcus aureus encoded by Tn4001. J Med. Microbio!. 24 139-144.
Hiramatsu, K., Aritaka, N., Hanaki, H., et al., 1997, Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350 1670-1673.
Johnson, A.P., 1998, Intermediate vancomycin resistance in Staphylococcus aureus a major threat or a minor inconvenience? Editorial. J. Antimicrob. Chemother. 42 289-291.
Kaatz, G.W., Seo, S.M., Dorman, N.J., and Lerner, A.L., 1990, Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis. J. Infect. Dis. 162: 103-108.
Kaatz, G.W., Seo, S.M., and Ruble, C.A., 1993, Efflux-mediated fluoroquinolone-resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 37: 1086-1094.
Levy, S.B., 1998, The challenge of antibiotic resistance. Sci. Am. 278 32-39.
Livermore, D.M., and Yuan, M., 1996, Antibiotic resistance and production of extended-spectrum β-lactamases amongst Klebsiella spp. from intensive care units in Europe. J.Antimicrob. Chemother. 39 409-424.
McGowan, J.E., Jr., and Metchock, B.G., 1995, Penicillin-resistant Pneumococci an emerging threat to successful therapy. J. Hosp. Infect. 30(Suppl): 472-482.
Medeiros, A.A., 1997, Evolution and dissemination of β-lactamases accelerated generations of β-lactam antibiotics. Clin. Infect. Dis. 24 (Suppl.l): S19-S45.
Moreira, B., Boule-Vavra, S., Boudewijn, L., Dejonge, M., and Daum RS., 1997, Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 41 1788-1793.
Morris, J.G., Shay, D.K., and Hebden, N., 1995, Enterococci resistant to multiple antimicrobial agents including vancomycin. Ann. Intern. Med.123: 250-259.
Muder, R.R., Brenne, C., Drenning, S.D., et al., 1997, Multiple antibiotic-resistant gram-negative bacilli in a long-term-care facility: a case -control study of patient risk factors and prior antibiotic use. Infect Control Hosp Epidemiol 18 809-813.
Mulder, J.G., Kosterink, J.G.W., and Degener, J.E., 1997, The relationship between the use of flucloxacillin, vancomycin, aminoglycosides and ciprofloxacin and the susceptibility patterns of coagulase-negative staphylococci recovered from blood cultures. J. Antimicrob. Chemother. 40 701-706.
Murray, B., 1997, Vancomycin-resistant enterococci. Am JMed 101 284-293.
M’Zali, F.H., Heritage, J., Gascoyne-Binzi, D.M., et al., 1997, Transcontinental importation into the UK of Escherichia coli expressing a plasmid-mediated AmpC-type betalactamase exposed during an outbreak of SHV-5 extended spectrum beta-lactamase in a Leeds Hospital. J Antimicrob. Chemother. 40 823-31.
Neu, H.C., 1992, The crisis in antibiotic resistance. Science 257: 1064-1073.
Pagano, L., Tacconelli, E., Tumbarello, M., et al., 1997, Teicoplanin-resistant coagulase-negative staphylococcal bacteraemia in patients with haematological malignancies: a problem of increasing importance. J. Antimicrob. Chemother. 40:5 738-740.
Peña, C., Pujol, M., Ardanuy, C., et al., 1998, Epidemiology and successful control of a large outbreak due to Klebsiella pneumonia producing extended-β lactamases. Antimicrob. Agents Chemother 1998; 42 53-58.
Perichon, B., Reynolds, P., and Courvalin, P.,1997, VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob Agents Chemother; 41: 2016-2018.
Report of the ASM task force on antibiotic resistance, 1995. American Society for Microbiology.
Rubinstein, E., and Rubinovitch, B., 1994, Treatment of severe infections caused by penicillin-resistant pneumococci. Role of third generation cephalosporins. Infection 22 (Suppl. 3): S161-166.
Schmitz, F-J., Hertel, B., Hofmann, B., et al., 1998, Letter. Relationship between mutations in the coding and promotor regions of norA genes in 42 unrelated clinical isolates of Staphylococcus aureus and the MICS for these strains. J. Antimicrob. Chemother. 42: 561-563.
Schmitz F-J, Lindenlauf E, Hofmann B., et al., 1998, The prevalence of low-and high-level mupirocin resistance in staphylococci from 19 European hospitals. J. Antimicrob. Chemother. 42: 489-495.
Schmitz, F-J., Fluit, A.C., Gondolf, M., et al, 1999, The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals. J. Antimicrob. Chemother. 43: 253-259.
Seppälä, H., Klaukka, T., Vuopio-Varkila, J., et al., 1997, The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N. Engl. J. Med. 337: 441-446.
Shannon, K., Fung, K., Stapleton, P., et al,1998, A hospital outbreak of extended-spectrum ß-lactamase-producing Klebsiella pneumonia investigated by RAPD typing and analysis of the genetics and mechanisms of resistance. J. Hosp Infect. 39 291-300.
Shannon, K., Stapleton, P., Xiang, X., et al., 1998, Extended spectrum β-lactamaseproducing Klebsiella pneumonia strains causing nosocomial outbreaks of infection in the United Kingdom. J. Clin. Microbiol. 36: 3105-3110.
Sieradzki, K., Tomasz, A., 1997, Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus. J. Bacteriol. 179 2557-2566.
Sieradzki, K., Roberts, R. B., Haber, S. W., Tomasz, A., 1999, The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N. Engl. J. Med. 340: 517-523.
Tenover, F.C., Lancaster, M.V., Hill, B.C., et al., 1998, Characterization of staphylococci with reduced susceptibilities to vancomycin and otherglycopeptides. J. Clin. Microbiol. 36: 1020-1027.
Van den Braak, N., Belkum, A., Van Keulen, M., et al., 1998, Molecular characterization of vancomycin-resistant enterococci from hospitalized patients and poultry products in the Netherlands. J. Clin. Microbiol. 36: 1927-32.
Verhoef, J., and Gupta, R., 1999, Surveillance of resistance against antimicrobial agents — a European perspective. J. Hosp. Infect. 43 Suppl: S93-S96.
Voss, A., Milatovic, D., Wallrauch-Schwarz, C., Rosdahl, V.T., and Braveny, I., 1994, Methicillin-resistant Staphylococcus aureus in Europe. Eur. J. Clin. Microbiol. Infect. Dis. 13 50-55.
Waldvogel, F.A., 1999, New resistance in Staphylococcus aureus. Editorial. N Engl. J. Med. 340: 556-557.
Weinstein, J.W., Roe, M., Towns, M., et al,1996, Resistant enterococci; a prospective study of prevalence, incidence and factors associated withcolonization in a university hospital. Infect. Control. Hosp. Epidemiol. 17 36-41.
WHO Regional Publications, 1997. Guidelines for Antimicrobial Resistance Surveillance. Eastern Mediterranean Series 15.
Woodford, N., Johnson, A.P., Morrison, D., and Speller, D.C.E., 1995, Currentperspectives on glycopeptide resistance. Clin. Microbiol. Rev. 8 585-615.
Wright, C.L., Byrne, M.E., Firth, N., and Skurray,R.A., 1988, A retrospective molecular analysis of gentamicin resistance in Staphylococcus aureus strains from UK hospitals J. Med. Microbiol. 47: 173-178.
Yoshida, H., Bogaki, M., Nakamura, S., et al., 1990, Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J. Bacteriol. 172: 6942-6949.
Yuk-Fong Liu, P., Tung, J-C., Ke, S-C., and Chen, S.L., 1998, Molecular epidemiology of extended-spectrum β-lactamase-producing Klebsiella pneumonia isolates in a district hospital in Taiwan. J. Clin. Microbiol. 36: 2759-2762.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Verhoef, J. (2003). Antibiotic Resistance: The Pandemic. In: Marzuki, S., Verhoef, J., Snippe, H. (eds) Tropical Diseases. Advances in Experimental Medicine and Biology, vol 531. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0059-9_26
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0059-9_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4905-1
Online ISBN: 978-1-4615-0059-9
eBook Packages: Springer Book Archive